东南亚医疗保健行业市场前景及投资研究报告-外文版培训课件2024.7temu

INDUSTRIES

&

MARKETSHealthcareinSoutheastAsiaCHAPTER

01OverviewGrossmedicalcosttrendratesworldwidefrom2021to2022withaforecastfor2023,byregionGrossmedicalcosttrendworldwidein2021-2023,byregion202120222023*0.2%0.18%0.16%0.14%0.12%0.1%18.9%18.2%15.1%12.4%11.5%10.5%10.2%9.8%9.4%9.1%8.6%8%0.08%0.06%0.04%0.02%0%6.9%6.5%5.6%LatinAmericaNorthAmericaAsiaPacificEuropeMiddleEastandAfrica4Description:In2023,thegrossmedicalcosttrendwasforecasttobethehighestintheLatinAmericanregion,reachingapproximately18.5percent.ThiswasfollowedbytheMiddleEastandAfricaregion,wheregrossmedicalcosttrendwasforecasttoreach11.5percent.ReadmoreNote(s):Worldwide;2021to2022;257respondents;amongleadinginsurersfrom55countries;*Forecastedvalue.ReadmoreSource(s):WillisTowersWatsonSpendingpercapitaonhealthcareexpenditureworldwidefrom2014to2029(inU.S.dollars)Spendingpercapitaonhealthcareexpenditureworldwide2014-20292,0001,8001,6001,4001,2001,000800600400200020142015201620172018201920202021202220232024202520262027202820295Description:Theglobalcurrenthealthcarespendingpercapitainwasforecasttocontinuouslyincreasebetween2024and2029byintotal281.8U.S.dollars(+18.4percent).Afterthefourteenthconsecutiveincreasingyear,thespendingisestimatedtoreach1,813.4U.S.dollarsandthereforeanewpeakin2029.ReadmoreNote(s):Worldwide;2014to2029;allvaluesareestimatesSource(s):SpendingpercapitaonhealthcareexpenditureinSoutheastAsiafrom2014to2029(inU.S.dollars)SpendingpercapitaonhealthcareexpenditureinSoutheastAsia2014-2029400350300250335.59317.5299.81283.13266.97251.29235.89220.56206.27191.5820015010050182.67171.56161.53152.07147.32145.07020142015201620172018201920202021202220232024202520262027202820296Description:ThecurrenthealthcarespendingpercapitainSoutheastAsiawasforecasttocontinuouslyincreasebetween2024and2029byintotal84.3U.S.dollars(+33.55percent).Afterthefourteenthconsecutiveincreasingyear,thespendingisestimatedtoreach335.59U.S.dollarsandthereforeanewpeakin2029.ReadmoreNote(s):Asia;2014to2029;allvaluesareestimatesSource(s):HospitalmarketrevenueinSoutheastAsiafrom2020to2029,bysegment(inbillionU.S.dollars)HospitalmarketrevenueSEA2020-2029,bysegmentInpatientCareOutpatientCareOtherHospitalServices100901.61.571.548027.81.521.4925.677023.541.4617.921.551.43605040302010019.671.391.371.3416.3115.1413.9913.1563.49202960.19202856.89202753.66202650.647.62202445.03202343.46202241.02202139.51202020257Description:In2024,thetotalrevenueofthehospitalmarketacrossSoutheastAsiawasestimatedtoamounttoaround67billionU.S.dollars.Inpatientcarewasthelargestsegment,accountingforanestimatedrevenueof47.6billiondollarsthatyear.

ReadmoreNote(s):Source(s):EstimatedhospitalmarketrevenueinSoutheastAsiafrom2020to2029,bycountry(inmillionU.S.dollars)HospitalrevenueSEA2020-2029,bycountryIndonesiaThailandVietnamSingaporeMalaysiaPhilippinesMyanmarCambodiaLaosBruneiTimor-Leste100,00090,00080,00070,00060,00050,00040,00030,00020,00010,000020202021202220232024202520262027202820298Description:In2024,Indonesia'shospitalmarketwasestimatedtogeneratearound20.95billionU.S.dollarsinrevenue,thehighestacrossSoutheastAsia.Allmarketsacrosstheregionwereforecasttogrowoverthenextfewyears.

ReadmoreNote(s):Source(s):CHAPTER

02HospitalsandhealthcarefacilitiesEstimatednumberofhospitalsinSoutheastAsiain2024,bycountryNumberofhospitalsSEA2024,bycountryNumberofhospitals02004006008001,0001,2001,4001,6001,8002,000PhilippinesThailandVietnamIndonesiaMyanmarMalaysiaLaos1,7531,3881,3321,070254147139CambodiaSingaporeTimor-LesteBrunei832714610Description:In2024,therewereanestimated1.75thousandhospitalsacrossthePhilippines.Incontrast,thereweresixhospitalsinBruneithatyear.ReadmoreNote(s):2024Source(s):TotalnumberofhospitalbedsinIndonesiafrom2020to2022NumberofhospitalbedsinIndonesia2020-2022450,000384,247400,000350,000300,000250,000200,000150,000100,00050,0000379,548371,19520202021202211Description:In2022,therewerearound384,200hospitalbedsinIndonesia.Inthatsameyear,thecountryhadaround2,561functioninghospitalsorrumahsakitumum.ReadmoreNote(s):Indonesia;2020to2022Source(s):MinistryofHealth(Indonesia)NumberofbedsinpublicandprivatehospitalsinMalaysiafrom2017to2022(in1,000s)NumberofbedsinpublicandprivatehospitalsinMalaysia2017-2022PublicPrivate5045.1744.8544.124540353025201510542.9442.342.4217.6317.7817.1616.4715.9614.8020172018201920202021202212Description:In2022,therewerearound45thousandbedsavailableinpublichospitalsinMalaysia,anincreasecomparedtothepreviousyear.Bycomparison,therewerearound17thousandbedsinprivatehospitalsinthesameyear.

ReadmoreNote(s):Malaysia;2017to2022Source(s):MinistryofHealthMalaysia;StatisticsMalaysiaNumberofbedsininpatienthealthcarefacilitiesinSingaporein2022,byfacilitytypeNumberofbedsininpatienthealthcarefacilitiesSingapore2022,byfacilitytypeNumberofbeds6,00002,0004,0008,00010,00012,00014,00016,00018,00020,000NursinghomesAcutehospitals18,15711,830Communityhospitals2,194Psychiatrichospitals1,950Inpatienthospicepalliativecareservice(IHPCS)26413/statistics/1230831/singapore-beds-in-inpatient-healthcare-facilities-by-facility-typeIn2022,therewere18,157nursinghomebedsinSingapore,accountingforthehighestshareofbedsininpatienthealthcarefacilitiesinthecountry.Inpatienthospicepalliativecarefacilitieshadthelowestshareofbeds,accountingforjust264.ReadmoreNote(s):Singapore;2022Source(s):MinistryofHealthSingapore;SingaporeDepartmentofStatisticsTotalnumberofhospitalbedsinThailandfrom2016to2023(in1,000s)TotalnumberofhospitalbedsThailand2016-202318016014012010080171.34171.36167.56166.31158.03150.09149.64141.560402002016201720182019202020212022202314Description:In2023,thetotalnumberofhospitalbedsinThailandamountedtoapproximately171.36thousand.Accordingtothesource,thenumberofhospitalbedsinThailandhasfluctuatedovertheyears.ꢀHealthcareindustryinThailandꢀ

AstheThaigovernmentpushestheThailand4.0policy,thehealthcareindustryisoneofthemostprioritizedsectorsinThailandforfurtherdevelopment,promotion,andinvestment.Thehealthandsocialworksectorsplayasignificantroleintheprosperity[...]

ReadmoreNote(s):Thailand;2016to2023Source(s):MOPH(Thailand)NumberofpatientbedsinVietnamfrom2010to2022(in1,000s)NumberofpatientbedsinVietnam2010-20223503002502001501005002010201120122013201420152016201720182019202020212022*15Description:In2022,therewereatotalof315.6thousandpatientbedsacrossallhealthestablishmentsinVietnam,indicatinganincreasefromthepreviousyear.Inthesameyear,therewere31.7patientbedspertenthousandinhabitantsinthecountry.

ReadmoreNote(s):Vietnam;2010to2022;*Preliminaryfigures.Accordingtothesource,thesefiguresexcludedpatientbedsofmedicalserviceunitincommunes,precintsandministries/agencies.Figuresfrom2015to2018excludedprivateestablishments.[...]

ReadmoreSource(s):GeneralStatisticsOfficeofVietnamCHAPTER

03HealthcarestaffNumberofmedicaldoctorsinIndonesiain2022,bytypeNumberofphysiciansinIndonesia2022,bytype160,000144,903140,000120,000100,00080,00060,00045,07835,81140,00020,00004,772GeneralpractitionerMedicalspecialistGeneraldentistDentalspecialist17Description:In2022,thenumberofgeneralpractitionersinIndonesiaamountedtonearly145,000.Bycomparison,therewere45,078doctorswhoworkedasmedicalspecialistsinthesameyear.

ReadmoreNote(s):Indonesia;2022Source(s):MinistryofHealth(Indonesia)NumberofregistereddoctorsinMalaysiafrom2015to2022(in1,000s)NumberofregistereddoctorsMalaysia2015-20229079.4477.76807060504030201007467.5961.1657.8350.0946.492015201620172018201920202021202218Description:In2022,thereweremorethan79,000registereddoctorsinMalaysia.ThecountrycurrentlyrankstenthwithintheaveragenumberofphysiciansperonethousandinhabitantsinAsia,with1.66physiciansper1,000inhabitants.ReadmoreNote(s):Malaysia;2015to2022Source(s):MinistryofHealthMalaysiaNumberofmedicalstaffinSingaporein2023,bytypeNumberofmedicalstaffinSingapore2023,bytypeNumberofmedicalstaff05,00010,00015,00020,00025,00030,00035,00040,00045,000RegisterednursesNon-specialistdoctorsEnrollednurses38,8349,7977,4576,956SpecialistdoctorsPharmacists3,989TraditionalChineseMedicinephysiciansOptometrists3,2092,712Physiotherapists2,6192,253GeneraldentalpractitionersOccupationaltherapistsSpeechtherapists1,551824465437OralhealththerapistsDentalspecialists19Description:In2023,therewerearound38,834registerednursesoperatinginSingapore.RegisterednursesmadeupthelargestgroupofmedicalstaffinSingapore,followedbynon-specialistdoctors.

ReadmoreNote(s):Singapore;2023Source(s):MinistryofHealthSingapore;SingaporeDepartmentofStatisticsNumberofdoctorsinThailandfrom2014to2023(in1,000s)NumberofdoctorsThailand2014-20234542.3739.1338.8240353025201510536.9436.4736.4735.3931.9631.4830.570201420152016201720182019202020212022202320Description:In2023,thenumberofdoctorsinThailandincreasedfromthepreviousyeartoaround42,400.Ontheotherhand,thenumberofphysiciansinthecountryhasfluctuatedsince2011.Incomparison,thenumberofpharmacistshasbeensteadilyincreasingsince2012.ReadmoreNote(s):Thailand;2014to2023;*Figureshavebeenrounded.

Databefore2023wasobtainedfromthepreviousreport.

ReadmoreSource(s):MOPH(Thailand)NumberofdoctorsinVietnamfrom2010to2022(in1,000s)NumberofdoctorsinVietnam2010-202212099.69810080604020095.787.484.877.573.874.471.868.665.162.861.42010201120122013201420152016201720182019202020212022*21Description:In2022,therewereatotalof99.6thousanddoctorsacrossallhealthestablishmentsinVietnam,indicatingaslightincreasefromthepreviousyear.Inthatyear,therewere10doctorpertenthousandinhabitants.

ReadmoreNote(s):Vietnam;2010to2022;*Preliminaryfigures.Datafrom2019to2021excludingnumberofdoctorsbelongingtocentralmanagement,datafrom2020to2021excludingnon-publicdoctors.

ReadmoreSource(s):GeneralStatisticsOfficeofVietnamCHAPTER

04MedicaltourismEstimatedannualnumberofmedicaltouristsinSoutheastAsiaasof2022,bycountryAnnualnumberofhealthtouristsSEA2022,bycountryEstimatednumberoftourists600,0000200,000400,000800,0001,000,0001,200,000ThailandMalaysia1,000,000800,000SingaporeVietnam500,000300,000Philippines200,00023Description:Asof2022,Thailandwasamedicaltourismdestinationforanestimatedonemillionvisitorsperyear.Malaysiahadthesecond-highestnumberofannualmedicaltourismvisitorsinSoutheastAsia,estimatedatover800thousand.

ReadmoreNote(s):Asia,Malaysia,Philippines,Singapore,Vietnam,Thailand,APAC;asof2022Source(s):IQVIA;MalaysiaHealthcareTravelCouncilTreatmentcostsforhipreplacementsinSoutheastAsiacomparedtotheUnitedStatesasof2021,bycountryComparativecostsforhipreplacementsurgeriesSEA2021,bycountry35,00031,00030,00025,00021,40020,00015,00010,0005,000016,50012,500UnitedStatesSingaporeThailandMalaysia24Description:Asof2021,ahipreplacementsurgeryinSingaporecostanestimated21.4thousandU.S.dollars,whichwasapproximately9.6thousandU.S.dollarslessexpensivethanintheUnitedStates.Thatyear,ahipreplacementsurgeryinMalaysiawaslessthanhalfthepriceofacomparabletreatmentintheUnitedStates.ꢀAlongsidethehighqualityofcareandaccesstotreatmentsunavailableelsewhere,lowerhealthcarecostsareoneofthemaindriversofmedicaltourismtoSoutheastAsian[...]

ReadmoreNote(s):Asia,Malaysia,Singapore,Thailand,APAC;asof2021;exchangeratesmayvarydependingontheyearSource(s):IQVIA;MalaysiaHealthcareTravelCouncil;PatientsBeyondBordersTreatmentcostsforkneereplacementsinSoutheastAsiacomparedtotheUnitedStatesasof2021,bycountryComparativecostsforkneereplacementsurgeriesSEA2021,bycountry30,00028,00025,00020,00015,00010,0005,000019,20013,2007,800UnitedStatesSingaporeThailandMalaysia25Description:Asof2021,akneereplacementsurgeryinSingaporewasapproximately8.8thousandU.S.dollarslessexpensivethanintheUnitedStates.Thatyear,akneereplacementsurgeryinMalaysiawasjustoveraquarterofthepriceofacomparabletreatmentintheUnitedStates.ꢀAlongsidethehighqualityofcareandaccesstotreatmentsunavailableelsewhere,lowerhealthcarecostsareoneofthemaindriversofmedicaltourismtoSoutheastAsiancountries.Thailand,Malaysia,and[...]

ReadmoreNote(s):Asia,Malaysia,Singapore,Thailand,APAC;asof2021;exchangeratesmayvarydependingontheyearSource(s):IQVIA;MalaysiaHealthcareTravelCouncil;PatientsBeyondBordersTreatmentscostsforcoronaryarterybypassgraft(CABG)surgeryinSoutheastAsiacomparedtotheUnitedStatesasof2021,bycountryComparativecostsforCABGsurgerySEA2021,bycountry100,00092,00090,00080,00070,00060,00050,00040,00030,00020,00010,000054,50033,00020,800UnitedStatesSingaporeThailandMalaysia26Description:Asof2021,acoronaryarterybypassgraft(CABG)surgeryinSingaporewasapproximately37.5thousandU.S.dollarslessexpensivethanintheUnitedStates.Thatyear,acoronaryarterybypassgraftinMalaysiawasjustaround23percentofthepriceofacomparabletreatmentintheUnitedStates.Alongsidethehighqualityofcareandaccesstotreatmentsunavailableelsewhere,lowerhealthcarecostsareoneofthemaindriversofmedicaltourismtoSoutheastAsiancountries.Thailand,[...]

ReadmoreNote(s):Asia,Malaysia,Singapore,Thailand,APAC;asof2021;exchangeratesmayvarydependingontheyearSource(s):IQVIA;MalaysiaHealthcareTravelCouncil;PatientsBeyondBordersCHAPTER

05PharmaceuticalindustryPharmaceuticalmarketrevenueinSoutheastAsiafrom2019to2023,withforecaststo2028,bysegment(inmillionU.S.dollars)PharmamarketrevenueSEA2019-2028,bysegmentOncologyDrugsAntiviralDrugsAnti-CoagulantsAnti-DiabetesDrugsImmunosuppressantsAnti-FibrinolyticsDrugsAnti-RheumaticDrugsBronchodilatorDrugsMultipleSclerosisDrugsVaccinesSensoryOrgansDrugsLipid-LoweringAgentsDermatologicalDrugsAnti-HypertensiveDrugsOtherPharmaceuticals18,00016,00014,00012,00010,0008,0006,0004,0002,0000201920202021202220232024*2025*2026*2027*2028*28Description:In2023,thepharmaceuticalindustryinSoutheastAsiageneratedapproximately12.74billionU.S.dollarsinrevenue.Oncologydrugsaccountedforaround2.1billiondollarsinrevenuethatyear.ReadmoreNote(s):Asia;2019to2023;*ForecastDataprovidedbyMarketInsightsareestimates.ThePharmaceuticalsmarketcoversremediesusedtocure,treat,prevent,anddiagnosediseases.Thesesmallmoleculedrugsorbiologicmedical[...]

ReadmoreSource(s):RevenueofthepharmaceuticalmarketinSoutheastAsiafrom2019to2023,withforecaststo2028,bycountry(inmillionU.S.dollars)PharmamarketrevenueSEA2019-2028,bycountryIndonesiaMalaysiaPhilippinesSingaporeThailandVietnam18,00016,00014,00012,00010,0008,0006,0004,0002,0000201920202021202220232024*2025*2026*2027*2028*29Description:In2023,SoutheastAsia'spharmaceuticalmarketgeneratedaround12.25billionU.S.dollars,markingadecreasefromover15billiondollarsinthepreviousyear.Indonesiaisthebiggestpharmaceuticalmarketintheregion,havinggeneratedapproximately3.35billiondollarsin2023.ReadmoreNote(s):Indonesia,Malaysia,Philippines,Singapore,Vietnam,Thailand;2019to2023Source(s):RevenueoftheOTCpharmaceuticalsmarketinSoutheastAsiafrom2019to2023,withforecaststo2028,bysegment(inmillionU.S.dollars)OTCpharmamarketrevenueSEA2019-2028,bysegmentAnalgesicsVitamins&MineralsWoundCareCold&CoughRemediesHandSanitizerOtherOTCPharmaceuticalsDigestives&IntestinalRemediesEyeCareSkinTreatmentSleepAids14,00012,00010,0008,0006,0004,0002,0000201920202021202220232024*2025*2026*2027*2028*30Description:Therevenueisforecasttoexperiencesignificantgrowthinallsegmentsin2028.Comparingthetendifferentsegmentsfortheyear2028,thesegment'Vitamins&Minerals'leadstherankingwith2.9billionU.S.dollars.Contrastingly,'WoundCare'isrankedlast,with85.9millionU.S.dollars.Theirdifference,comparedtoVitamins&Minerals,liesat2.8billionU.S.dollars.ReadmoreNote(s):Asia;2019to2023;*ForecastDataprovidedbyMarketInsightsareestimates.Definition:TheOver-the-CounterPharmaceuticalsmarketincludesnon-prescriptionmedications,treatments,andhealthcareproductsthatare[...]

ReadmoreSource(s):RevenueoftheOTCpharmaceuticalsmarketinSoutheastAsiafrom2016to2023,withforecaststo2028,bycountry(inmillionU.S.dollars)OTCpharmamarketrevenueSEA2016-2028,bycountryBruneiCambodiaIndonesiaLaosMalaysiaMyanmarPhilippinesSingaporeThailandTimor-LesteVietnam14,00012,00010,0008,0006,0004,0002,0000201620172018201920202021202220232024202520262027202831Description:Therevenueisforecasttoexperiencesignificantgrowthinallregionsin2028.Fromtheselectedregions,therankingbyrevenueintheotcpharmaceuticalsmarketisforecasttobeleadbyIndonesiawith4.1billionU.S.dollars.Incontrast,therankingistrailedbyTimor-Lestewith6.84millionU.S.dollars,recordingadifferenceof4.1billionU.S.dollarstoIndonesia.ReadmoreNote(s):Brunei,Myanmar[Burma],Cambodia,Indonesia,Laos,Malaysia,Philippines,Timor-Leste,Singapore,Vietnam,Thailand;2016to2023;*ForecastDataprovidedbyMarketInsightsareestimates.Definition:TheOver-the-Counter[...]

ReadmoreSource(s):TradebalanceofpharmaceuticalproductsinSoutheastAsiain2022,bycountry(inmillionU.S.dollars)PharmatradebalanceSEA2022,bycountryTradebalanceinmillionU.S.dollarsSingaporeTimor-LesteLaos5,070.56-13.26-82.99-141BruneiCambodiaMyanmarIndonesiaMalaysiaVietnam-356.9-605.09-909.99-1,753-2,547.29-2,630.82PhilippinesThailand-3,095.6532Description:In2022,SingaporehadapharmaceuticalproducttradebalanceofapproximatelyfivebillionU.S.dollars.Thatyear,SingaporewastheonlycountryinSoutheastAsiawithatradesurplusforpharmaceuticalproducts.Incontrast,Thailandhadthebiggestpharmaceuticaltradedeficitatoverthreebilliondollars.ReadmoreNote(s):Asia;2022Source(s):TradeMap;UNComtradeCHAPTER

06MedicaltechnologyindustryEstimatedmedicaltechnologymarketrevenueinSoutheastAsiafrom2020to2029,bysegment(inbillionU.S.dollars)MedTechmarketrevenueSEA2020-2029,bysegmentInVitroDiagnosticsMedicalDevices2520151050202020212022202320242025202620272028202934Description:In2024,themedicaltechnologymarketinSoutheastAsiageneratedanestimated13.4billionU.S.dollarsinrevenue.Themedicaldevicessegmentgeneratedaround11.5billiondollarsintheregionthatyear.

ReadmoreNote(s):2020to2029Source(s):EstimatedmedicaltechnologymarketrevenueinSoutheastAsiain2024,bycountry(inmillionU.S.dollars)MedTechrevenueSEA2024,bycountryRevenueinmillionU.S.dollars05001,0001,5002,0002,5003,0003,5004,000MalaysiaThailand3,592.582,674.612,586.11IndonesiaVietnam1,896.52SingaporeMyanmar1,256.33279.18CambodiaBruneiDarussalamLaos93.0956.922.39Timor-Leste

13.8235Description:In2024,MalaysiahadthelargestmedicaltechnologymarketinSoutheastAsia,generatinganestimated3.6billionU.S.dollarsinrevenue.Thailandfollowed,reachingarevenueofapproximately2.7billiondollarsthatyear.ReadmoreNote(s):2024Source(s):ShareoffundingdealsinthemedicaldevicesanddigitalhealthsectorinSoutheastAsiabetween1stquarter2020and1stquarter2023,bycountryMedTechfundingdealsshareSEAQ12020-Q12023,bycountryShareoftotalfunding0%5%10%15%20%25%30%35%40%39%45%SingaporeMalaysiaVietnam23%16%IndonesiaThailand13%7%Philippines2%36Description:Betweenthefirstquarterof2020andthefirstquarterof2023,SingaporewastheleadingrecipientoffundinginthemedicaldevicesanddigitalhealthsectorinSoutheastAsia,accountingfor39percentoftotalfundingintheregion.Malaysiafollowedwithafundingshareof23percent.ReadmoreNote(s):Asia,APAC;Q12020toQ12023Source(s):JahaniandAssociates;PitchBookLargestdealsinthemedicaldevicesanddigitalhealthsectorinSoutheastAsiafrom1stquarter2020to1stquarter2023,byfundingshareTenlargestMedTechfundingdealsSEAQ12020-Q12023,byfundingshareShareoftotalfunding*0%5%10%15%20%25%VinmecInternationalHospitalSunwayHoldingsHalodoc23%20%9%CEI8%DoctorAnywhereFourierIntelligenceEudaHealth7%7%7%7%MicrofiberIndustriesPTJayamasIndustriesFiammaHoldings6%5%37Description:Betweenthefirstquarterof2020andthefirstquarterof2023,VinmecInternationalHospitalaccountedforthelargestfundingshareamongthetoptendealsinthemedicaldevicesanddigitalhealthsectoracrossSoutheastAsia.VinmecisaVietnameseoperatorofhospitalsandclinics.At20percent,fundingreceivedbyMalaysianhealthcarecompanySunwayHoldingsaccountedforthesecond-largestsharewithinthisperiod.ReadmoreNote(s):Asia,APAC;Q12020toQ12023;*ValuesrepresenttheshareeachdealheldamongtheleadingtenmedicaldevicesanddigitalhealthsectorfundingdealsinSoutheastAsia.ReadmoreSource(s):JahaniandAssociates;PitchBookCHAPTER

07ConsumerperspectiveLeadinghealthconcernsthatconsumersdesiredtoresolveinSoutheastAsiaasofJanuary2023,bycountryLeadinghealthchallengestoresolveSEA2023,bycountryIndonesiaMalaysia29.94%12.92%24.07%28.96%11.15%9.98%Philippines40.36%12.42%17.16%15.52%20.1%Thailand24.22%8.91%Vietnam44.21%24.74%16.32%15.44%15.26%14.21%11.75%8.42%7.19%5.96%2.63%%OverallhealthandwellnessHearthealth12.39%6.27%35.33%4.99%6.7%Weightissue20.35%20.74%17.25%8.33%WeightmanagementImmunehealthDigestivehealth,fillingnutritionalgapsHair,skinandnailshealthHealthyaging2.56%5.84%11.25%6.13%8.12%0.28%0.14%11.93%18.63%20.26%7.35%27.01%9.59%17.64%23.26%4.65%Lackofenergy10.57%17.61%0.2%EnergyandperformanceOthers12.42%0.33%7.75%0.58%Noneo